Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

bafisontamab (EMB-01)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

EpimAb Biotherap

Drug class:

EGFR inhibitor, c-MET inhibitor

Related drugs:

‹

PF-04217903 (0)

cetuximab (347)

osimertinib (301)

erlotinib (235)

gefitinib (194)

panitumumab (123)

lapatinib (107)

neratinib (102)

brigatinib (50)

aumolertinib (39)

amivantamab-vmjw (25)

firmonertinib (14)

mobocertinib (12)

lazertinib (12)

tarloxotinib bromide (7)

nimotuzumab (6)

rociletinib (5)

tomuzotuximab (4)

necitumumab (3)

befotertinib (3)

sunvozertinib (3)

zorifertinib (3)

ABP 494 (cetuximab biosimilar) (1)

Compound 6a (1)

abivertinib (1)

sevabertinib (1)

STI-001 (cetuximab biosimilar) (0)

antroquinonol (0)

zalutumumab (0)

JNJ-26483327 (0)

asandeutertinib (0)

PF-08046052 (0)

rindopepimut (0)

Undisclosed EGFR inhibitor (0)

cetuximab biosimilar (0)

PF-06747775 (0)

JNJ-64041757 (0)

savolitinib (29)

capmatinib (23)

unecritinib (6)

gumarontinib (5)

JNJ-38877605 (1)

EMD 1204831 (0)

PF-04217903 (0)

›